Poly Medicure Limited · NSE:POLYMED

Poly Medicure — Investor Presentation (May 2023)

31 slides from Poly Medicure's investor presentation, May 2023

  1. Slide 1: Investors Presentation May 2023

    Slide 1: Investors Presentation May 2023

    Investors Presentation May 2023 www.polymedicure.com Confidential I Slide 1

  2. Slide 2: Disclaimer

    Slide 2: Disclaimer

    DISCLAIMER This presentation has been prepared by Poly Medicure Limited (the “Company”) solely for your information and may not be distributed, reproduced, or redistributed or passed on directly or indirectly to any other person, whether within or outside your organization or firm, or published in w

  3. Slide 3: Table of Contents

    Slide 3: Table of Contents

    Table of Contents Polymed at a Glance 4 Board of Directors 9 Manufacturing Excellence 11 Research and Development 15 Sustainability Reporting 17 Financial Data 19 Medical Devices Policy 2023 23 Way Forward 26 Capex Update 27 Awards and Corporate Communication 28 www.polymedicure.com Confidential I S

  4. Slide 4: Polymed at a Glance

    Slide 4: Polymed at a Glance

    Polymed at a Glance 300+ 125+ INR 1115 Crores 30+ 160+ Sales Associates Countries Consolidated Revenue Clinical Specialists Medical Devices Largest Exporter of 3000+ 1 Billion+ consumable Medical devices, Devices Manufacturing Employee Base 9 yrs in a row Capacity per year www.polymedicure.com Confi

  5. Slide 5: Portfolio of more than 160+ Medical Devices

    Slide 5: Portfolio of more than 160+ Medical Devices

    Polymed’s Unique Position EMINENCE IN FLUID MANAGEMENT DISPOSABLES AND PROCEDURAL MEDICAL DEVICES COMPREHENSIVE PRODUCT RANGE Oncology Infusion & Vascular Access Molecular Diagnostics Gastroentrology Urology Critical Care Renal Care & Anaesthesia & Dialysis Respiratory Care Surgery and Wound Drainag

  6. Slide 6: Our Journey

    Slide 6: Our Journey

    Our Journey…..….. A SUCCESSFUL STORY SPANNING OVER 25 YEARS 1997 2001 2002 2004 2007 2009 2011 Commencement of Expansion of JV in Egypt Faridabad Plant-2 New Plant China Plant Company Manufacturing Faridabad Plant Extension (100% Haridwar Listed in NSE Operation EOU) 2014 2016 2018 2020 2021 *2023 *

  7. Slide 7: Corporate Structure

    Slide 7: Corporate Structure

    Corporate Structure POLYMED GROUP INDIA OVERSEAS Poly Medicure Poly Medicure BV- Ultra for Medical (Laiyang) Co. Ltd. Netherlands Poly Medicure Ltd Products Co. China Wholly owned (UMIC) – Egypt Holding Co. Wholly owned Subsidiary Associate (23%) Subsidiary (100%) (100%) Plan 1 Health India Pvt. Ltd

  8. Slide 8: 2020-2025 Vision

    Slide 8: 2020-2025 Vision

    2020-2025 Vision TRANSFORM FROM A PRODUCT COMPANY TO A SOLUTION PROVIDER ORGANIZATION Started in 1997 2002-2009 2011-2019 2020-2021 2022-2025 2026 and beyond Commencement of Product and facility New R&D Center • Focus on commercial • Launch differentiated • Globally recognized Manufacturing expansio

  9. Slide 9: Board of Directors & Management

    Slide 9: Board of Directors & Management

    Board of Directors & Management Mr. Devendra Raj Mehta (Chairman, Non-Executive Independent Director) Mr. Himanshu Baid Mr. Rishi Baid (Managing Director) (Joint Managing Director) Mrs. Mukulika Baid Dr. Shailendra Raj Mehta Mr. Jugal Kishore Baid (Non-Executive Director) (Non-Executive (Non-Executi

  10. Slide 10: Executive Global Leadership

    Slide 10: Executive Global Leadership

    Executive Global Leadership Building out Geographical Leadership with strong medical device experience & expertise Heyward Powe Xue Wendong VP Sales & Business General Manager , China Development, North & Central America Alessando Balboni Prof. Sergio Bertoglio • 20 years Medical Device • 24 years M

  11. Slide 11: Across the World, We serve people in over 125+ countries

    Slide 11: Across the World, We serve people in over 125+ countries

    Across the World, We serve people in over 125+ countries Our Growth Verticals 4 new Plants under Construction UNIQUELY POSITIONED TO PROVIDE VALUE TO OUR CUSTOMERS www.polymedicure.com Confidential I Slide 11

  12. Slide 12: Manufacturing

    Slide 12: Manufacturing

    Manufacturing (INDIA, ITALY, EGYPT, CHINA) 1st Medical Device Company from India to have overseas plants. Faridabad Plant, India Haridwar Plant, India IMT Faridabad India Over 300+ Moulding Machines & 1200+ Injection Molds More than 200+ automatic Faridabad Plant, India Jaipur Plant, India R & D Cen

  13. Slide 13: Manufacturing Excellence

    Slide 13: Manufacturing Excellence

    Manufacturing Excellence www.polymedicure.com Confidential I Slide 13

  14. Slide 14: Manufacturing Excellence

    Slide 14: Manufacturing Excellence

    Manufacturing Excellence www.polymedicure.com Confidential I Slide 14

  15. Slide 15: Research and Development Capabilities

    Slide 15: Research and Development Capabilities

    Research and Development Capabilities Product Design Tooling • Mold Design & & Development Development • Product Design using CAD Software ProE Creo, • Mold Flow Analysis for Solidworks, NX, AutoCAD simulation 1 2 • Dedicated R&D Quality Lab • VMC, CNC machines for Design Verification EDM/Wirecut/Mi

  16. Slide 16: Research and Development Capabilities: Manufacturing Process

    Slide 16: Research and Development Capabilities: Manufacturing Process

    Research and Development Capabilities Manufacturing Process Processing capabilities • Cannula manufacturing • Injection Molding • Ultrasonic Welding Horizontal M/C’s • Radio Frequency Welding • Insert Molding (Vertical M/C’s) • Thermal Bonding • Extrusion (PVC, PU, FEP) • Hot Air Welding • Laser Wel

  17. Slide 17: Sustainability & MDSAP Certifications

    Slide 17: Sustainability & MDSAP Certifications

    Sustainability & MDSAP Certifications ISO-14001 MDSAP www.polymedicure.com Confidential I Slide 18

  18. Slide 18: Stickiness in customer base & sustainable business

    Slide 18: Stickiness in customer base & sustainable business

    Stickiness in customer base & sustainable business LEVERAGE OUR (CUSTOMER) INSTALLED BASE AND DISTRIBUTOR NETWORK TO LAUNCH NEW PRODUCTS Polymed Sales By Geography Polymed Sales By Product Category Polymed Brand and OEM Private Label Sales 9% 7% 30% 32% 3% 4% 10% 68% 67% 70% 4% 3% Export India Infus

  19. Slide 19: Our Strength: Consistent all-round growth (Consolidated)

    Slide 19: Our Strength: Consistent all-round growth (Consolidated)

    Our Strength: Consistent all-round growth (Consolidated) ₹ ₹ ₹ REVENUE (₹ Crs) EBIDTA (₹ Crs) PBT (₹ Crs) PAT (₹ Crs) 1200.00 1115.23 923.06 300.00 269.38 250.00 237.49 200.00 179.28 1000.00 786.20 250.00 195.24 800.00 214.34 213.10 200.00 180.04 150.00 135.84146.51 200.00 600.00 150.00 150.00 100.0

  20. Slide 20: Creating Value for Shareholders

    Slide 20: Creating Value for Shareholders

    Creating Value for Shareholders Increasing Shareholders Base Creating Value for Shareholders NO. OF SHAREHOLDERS MARKET CAP IN INR (CRS) 40000 35393 10000 9105.74 9140.14 33831 9000 35000 7884.74 8000 30000 7000 25000 21531 6000 20000 5000 15000 4000 10000 8574 3000 2056.36 2000 5000 1000 0 0 No of

  21. Slide 21: Ratios

    Slide 21: Ratios

    Ratio’s Interest Coverage Debt Service Coverage 70 64.53 12 9.91 60 10 50 41.34 8 6.87 40 5.55 29.58 6 4.61 30 20 14.32 4 10 2 0 0 % % FY 2020 FY 2021 FY 2022 FY 2023 FY 2020 FY 2021 FY 2022 FY 2023 ROCE 30.00% 21.03% 20.00% 15.49% 14.05% 16.47% 10.00% 0.00% % FY 2020 FY 2021 FY 2022 FY 2023 * Incre

  22. Slide 22: Performance Standalone/Consolidated

    Slide 22: Performance Standalone/Consolidated

    Performance Standalone/Consolidated Poly Medicure Ltd 1068.05 Standalone in INR Crs Consolidated in INR Crs 1115.23 1200.00 1200.00 879.36 923.06 1000.00 1000.00 747.38 786.20 800.00 800.00 600.00 600.00 268.48 400.00 269.38 236.88 400.00 237.49 212.13 208.30 194.72 214.34 213.10 179.04 195.24 173.3

  23. Slide 23: New National Medical Devices Policy 2023

    Slide 23: New National Medical Devices Policy 2023

    New National Medical Devices Policy 2023 Vision: ✓ Accelerated growth path with a patient-centric approach ✓ To emerge as the global leader in the manufacturing and innovation of medical devices by achieving 10-12% share in the expanding global market over the next 25 years. ✓ Policy is expected to

  24. Slide 24: New National Medical Devices Policy 2023

    Slide 24: New National Medical Devices Policy 2023

    New National Medical Devices Policy 2023 Strategies to Promote Medical Device Sector: • Regulatory Streamlining: creation of a Single Window Clearance System, enhancing the Role of BIS and designing a coherent pricing regulation. • Enabling Infrastructure: The establishment and strengthening of larg

  25. Slide 25: Production Linked Incentive Scheme (I & II)

    Slide 25: Production Linked Incentive Scheme (I & II)

    Production Linked Incentive Scheme (I & II) • Polymed got approval under Renal Care Segment.New Cardio range to be added • Committed Investment of 70 Crs under the scheme from FY 2022-28 • 25.5 Crs of Investment done upto Mar-23 under the scheme • Polymed got approval under In Vitro Diagnostic Medic

  26. Slide 26: Way Forward

    Slide 26: Way Forward

    Way Forward … International Strategy Vascular Access • Transition to MDR • Be a leading global player 04 • Improve Brand visibility in • Expand footprint in Europe & International markets USA 01 • Received US FDA 510(K) clearance for two products Renal Promote Infection • Introduce Indigenous Dialys

  27. Slide 27: Capex Update

    Slide 27: Capex Update

    Capex Update • Capex incurred in FY 2022-23 : INR 237 Crs • Capex planned for FY 2023-24 : INR 200 Crs Faridabad Manufacturing and Premises under Construction as on 31st March 2023 Warehouse 56A Scheduled Operation Q1 -2023-24 Jaipur SEZ Phase - II Faridabad Plant 117 Faridabad IMT Plant II Schedule

  28. Slide 28: Awards & Recognition

    Slide 28: Awards & Recognition

    Awards & Recognition “Top 50 Innovative Companies Award 2022” By Confederation of Indian Industry – Received in December 2022 www.polymedicure.com Confidential I Slide 28

  29. Slide 29: Corporate Communication

    Slide 29: Corporate Communication

    Corporate Communication Media I Industry Events I Webinars| Social Media I Clinical Engagements I Conferences 1 lac + followers on social media, 250 posts pushed last year Annual Summit 2022 www.polymedicure.com Confidential I Slide 29

  30. Slide 30: Corporate Communication

    Slide 30: Corporate Communication

    Corporate Communication Media I Industry Events I Webinars| Social Media I Clinical Engagements I Conferences ARAB HEALTH 2023, Dubai MEDICA 2022, Germany INS Annual Conference 2022, Delhi ISNCON 2022, Pune www.polymedicure.com Confidential I Slide 30

  31. Slide 31: Thank You

    Slide 31: Thank You

    Poly Medicure Limited Thank You Registered Office: 232 B, 3rd Floor, Okhla Industrial Estate, Phase III, New Delhi-110020, India Tel:- 91-11-33550700, 47317000, 26321838/99 For any general queries, Reach us at: info@polymedicure.com Visit: www.polymedicure.com www.polymedicure.com Confidential I Sli

Source: Internet Archive copy of polymedicure.com

More decks from Poly Medicure Limited

All 34 Poly Medicure decks